Max Blau
Grist
Atlanta, GA, United States
Contact Max
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Max:
How a powerful company convinced Georgia to let it bury toxic waste in groundwater
Documents reveal Georgia Power went to great lengths to advocate for risky waste storage. → Read More
The Coal Plant Next Door
Near America's largest coal plant, there are toxins in the water and people are falling ill. One energy plant plans to avoid cleanup costs. → Read More
In Florence's path, drug plants avoided worst-case scenarios
Most drug manufacturing plants in the path of Florence stayed open during the storm or had reopened by Monday morning, officials said. → Read More
Donations of $4,500 overdose antidote were PR gold for drug maker — but some kits were close to expiring
Auto-injectors with the naloxone overdose antidote donated to some police agencies through the Kaleo Cares program were just months away from expiration. → Read More
Small town grapples with growth of the world’s largest insulin maker
The tiny town of Clayton, N.C., seems an unlikely place for the world’s largest insulin maker to manufacture drugs that fight a chronic disease affecting 30 million Americans. → Read More
The next generation of doctors may be learning bad habits at teaching hospitals with many safety violations
A STAT analysis of federal inspection data finds that there’s a wide gap in the quality of training at teaching hospitals, as shown by how frequently these hospitals are cited for deficiencies. → Read More
The next naloxone? Companies, academics search for better overdose-reversal drugs
Drug makers, researchers, and health officials are eagerly eyeing the development of new treatments to augment the use of naloxone or, in some cases, potentially replace it. → Read More
Patients would like their data, please. Will the medical device industry listen?
Personal medical devices are still black boxes, off-limits to patients and caregivers. The industry, slow to adapt, has grappled with concerns over security, privacy, and patient safety. → Read More
Risky tactic, desperate need: Trial to test brain implants for opioid addiction
A trial later this year could be the first in the U.S. to rigorously test deep brain stimulation (DBS) as a treatment for opioid addiction. But brain surgery carries hefty risks — and its effectiveness is an open question. → Read More
Humans may be able to pick out sick people just by looking at their faces
We may subconsciously avoid infection by spotting markers of illness — pale skin, tired eyes — and staying away from those individuals. → Read More
3 hospital CEOs to watch in 2018
Because of the industry’s volatility, in 2017, the CEOs of major hospitals postponed expansion plans and those leading nonprofit chains considered massive mergers. What will the new year bring? → Read More
Temporary doctors are no worse for patients' health, study finds
Doctors who are employed under short-term contracts — called locum tenens — provided a similar level of care as staff doctors, a study found. → Read More
FDA approves Indivior’s monthly injection to treat opioid addiction
A new form of a widely used opioid addiction treatment that is injected monthly instead of taken daily as a tablet was approved Thursday by the FDA. → Read More
Trump is donating his salary to fight the opioid crisis. Here's what it would buy
President Trump is donating his $100,000 salary for the third quarter of this year to combat the opioid crisis. What would that money buy? Not much. → Read More
How a stepson’s addiction drove a father to try to develop a safer opioid
Bill Crossman is an unlikely candidate to be the head of a pharmaceutical firm. → Read More
Long-awaited study finds monthly Vivitrol as effective as daily pill for opioid addiction
The finding from the largest head-to-head study to date between two leading drugs to treat opioid addiction could dramatically change prescribing habits. → Read More
FDA clears electronic earpiece to block opioid withdrawal symptoms
A wearable device claiming to block the pain of opioid withdrawal has been cleared by the Food and Drug Administration under a new expedited review process. → Read More
A new study could upend how we treat opioid addiction
The largest head-to-head study to date between two leading drugs to treat opioid addiction has found them roughly equivalent. → Read More
This advocate is fighting to turn patients into scientists
Dana Lewis didn’t like how slowly health companies moved to improve medical technology for patients with diabetes. So she took a DIY approach. → Read More
'Extraordinary' tale: Stem cells heal a young boy's lethal skin disease
Doctors were able to reconstruct 80 percent of the boy’s skin by grafting on genetically modified stem cells, the most extensive such procedure ever done. → Read More